• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受电凝治疗人群患宫颈癌的风险。

Risk of cervical cancer among an electrocoagulated population.

作者信息

Kauraniemi T, Räsänen-Virtanen U, Hakama M

出版信息

Am J Obstet Gynecol. 1978 Jul 1;131(5):533-8. doi: 10.1016/0002-9378(78)90115-1.

DOI:10.1016/0002-9378(78)90115-1
PMID:307910
Abstract

In Finland an organized mass screening program covers the total female population. Based on the material (429,832) from a nationwide mass screening registry it was estimated that the female population not subjected to electrocoagulation of the uterine cervix (362,511) had a sixfold risk of frankly invasive carcinoma, a fourfold risk of carcinoma in situ or dysplasia of high degree, and a twofold risk of dysplasia of low degree as compared with the female population subjected to electrocoagulation of the uterine cervix (67,321). The relative risk of cervical lesion varied by cytologic diagnosis, marital status, and Trichomonas vaginalis.

摘要

在芬兰,一项有组织的大规模筛查项目覆盖了全体女性人口。根据全国大规模筛查登记处的资料(429,832例)估计,未接受子宫颈电凝术的女性人群(362,511例)患明显浸润性癌的风险是接受子宫颈电凝术的女性人群(67,321例)的6倍,患原位癌或高度发育异常的风险是其4倍,患低度发育异常的风险是其2倍。宫颈病变的相对风险因细胞学诊断、婚姻状况和阴道毛滴虫而有所不同。

相似文献

1
Risk of cervical cancer among an electrocoagulated population.接受电凝治疗人群患宫颈癌的风险。
Am J Obstet Gynecol. 1978 Jul 1;131(5):533-8. doi: 10.1016/0002-9378(78)90115-1.
2
Electrocoagulation and the risk of cervical neoplasia.电凝与宫颈肿瘤形成的风险。
Obstet Gynecol. 1985 Nov;66(5):703-7.
3
[Significance of variations in the size of Trichomonas vaginalis in patients with dysplasia, intrapithelial and invasive planocellular carcinoma of the uterine cervix].
Jugosl Ginekol Opstet. 1979 Jan-Feb;18(1):15-9.
4
Prospective and randomised public-health trial on neural network-assisted screening for cervical cancer in Finland: results of the first year.芬兰神经网络辅助宫颈癌筛查的前瞻性随机公共卫生试验:第一年的结果
Int J Cancer. 2003 Jan 20;103(3):422-6. doi: 10.1002/ijc.10839.
5
Colposcopy and electrocoagulation-diathermy for cervical dysplasia and carcinoma in situ.阴道镜检查及电凝透热疗法治疗宫颈发育异常和原位癌。
Obstet Gynecol. 1971 Apr;37(4):623-8.
6
Effect of a mass screening program on the risk of cervical cancer.大规模筛查计划对宫颈癌风险的影响。
Am J Epidemiol. 1976 May;103(5):512-7. doi: 10.1093/oxfordjournals.aje.a112253.
7
Comprehensive cytologic screening in patients undergoing voluntary abortions.对自愿堕胎患者进行全面的细胞学筛查。
Am J Obstet Gynecol. 1974 Jan 1;118(1):102-5. doi: 10.1016/s0002-9378(16)33652-3.
8
False negative rate in cervical cytology.宫颈细胞学检查中的假阴性率。
J Clin Pathol. 1987 Apr;40(4):438-42. doi: 10.1136/jcp.40.4.438.
9
Incidence and prevalence of preclinical carcinoma of cervix in a British population.英国人群中宫颈临床前期癌的发病率和患病率。
Br J Obstet Gynaecol. 1982 Jul;89(7):564-70. doi: 10.1111/j.1471-0528.1982.tb03661.x.
10
Screening errors in cervical cytologic screening.宫颈细胞学筛查中的筛查错误。
Acta Cytol. 1987 Jul-Aug;31(4):434-8.

引用本文的文献

1
Deciphering the Multifactorial Susceptibility of Mucosal Junction Cells to HPV Infection and Related Carcinogenesis.解析黏膜交界细胞对人乳头瘤病毒感染及相关致癌作用的多因素易感性
Viruses. 2017 Apr 20;9(4):85. doi: 10.3390/v9040085.
2
Cervical cancer: squamocolumnar junction ablation--tying up loose ends?宫颈癌:鳞柱交界消融术——收尾工作?
Nat Rev Clin Oncol. 2015 Jul;12(7):378-80. doi: 10.1038/nrclinonc.2015.104. Epub 2015 Jun 2.
3
Past and future of prophylactic ablation of the cervical squamocolumnar junction.宫颈鳞柱交界预防性消融的过去与未来
Ecancermedicalscience. 2015 Apr 29;9:527. doi: 10.3332/ecancer.2015.527. eCollection 2015.
4
Evidence for benefits from treating cervical ectopy: literature review.治疗宫颈糜烂的益处的证据:文献综述
Sao Paulo Med J. 2008 Mar 6;126(2):132-9. doi: 10.1590/s1516-31802008000200014.
5
Herpes simplex virus type 2 infection and cervical cancer: a prospective study of 12 years of follow-up in Finland.
Cancer Causes Control. 1992 Jul;3(4):333-8. doi: 10.1007/BF00146886.